Logo
April 29, 2014 12:00 UTC

Gordian Surgical Completes $1 Million Raise

TEL AVIV, Israel--(BUSINESS WIRE)-- Gordian Surgical, a portfolio company of Trendlines Medical, recently completed a $1 million raise. Participants in the raise included angel investors, surgeons, and a private investment fund. Due to the interest in the Gordian technology, not only was the raise accomplished quickly but it exceeded the target by 30%.

Gordian’s two-in-one trocar with a built-in closure device offers a safe, economical approach for opening and suturing abdominal incisions during laparoscopic procedures. Instead of inserting the sutures at the end of the procedure, using Gordian’s uniquely designed release mechanism sutures are inserted into the tissue surrounding the opening at the beginning of the procedure. The sutures and anchors to hold them stay in place throughout the operation the incisions are closed efficiently when the Gordian trocar is removed.

An estimated 4.4 million laparoscopic procedures are performed annually in the United States. While laparoscopic procedures offer a minimally invasive surgical option, closing the numerous access ports (openings) remains a challenging, time-consuming task. Gordian Surgical’s novel trocar provides a straightforward solution to this challenge.

Zvi Pe’er, CEO of Gordian Surgical, remarks: “I am extremely pleased by the level of interest in our technology and the speed with which we closed the investment round. The fact that three surgeons made investments and recommendations from other surgeons support the clinical need and strongly reinforce the solution that we are developing.”

The funds will be used to finalize product design, receive regulatory clearance (FDA and CE mark), and perform clinical validations.

Eran Feldhay, CEO of Trendlines Medical, adds: “In a relatively short time, Gordian Surgical has made amazing strides and achievements. We are proud of this young company that has the capability of bringing a truly innovative solution to the operating theater.”

About The Trendlines Group
The Trendlines Group (www.trendlines.com) invests in, incubates, and supports early-stage, medical and agricultural technology companies in Israel, a global leader in start-up ingenuity. Trendlines Medical, our investment unit for medical innovation, works in partnership with innovators and investors, in an environment that encourages curiosity and fosters collaboration. Simply stated, Trendlines creates and develops companies to improve the human condition.

Contacts

Ofir Shpigel Media and Public Relations
Media relations:
Efrat Kaduri, 04-9535030
Efrat@ofirpr.co.il


Source: Trendlines